CVS Health (CVS) to Release Quarterly Earnings on Wednesday

Key Points

• CVS Health is set to release its Q3 2025 earnings on October 29, 2025, with analysts expecting earnings of $1.36 per share and revenue of $98.8459 billion.
• The company recently announced a quarterly dividend of $0.665 to be paid on November 3rd, representing an annualized dividend yield of 3.2%.
• Analysts have provided a largely positive outlook on CVS Health, with targets ranging from $87 to $92, reflecting confidence in the company's performance.

CVS Health (NYSE:CVS - Get Free Report) is anticipated to issue its Q3 2025 results before the market opens on Wednesday, October 29th. Analysts expect CVS Health to post earnings of $1.36 per share and revenue of $98.8459 billion for the quarter. CVS Health has set its FY 2025 guidance at 6.300-6.400 EPS.Interested persons are encouraged to explore the company's upcoming Q3 2025 earningoverview page for the latest details on the call scheduled for Wednesday, October 29, 2025 at 8:00 AM ET.

CVS Health (NYSE:CVS - Get Free Report) last released its quarterly earnings data on Thursday, July 31st. The pharmacy operator reported $1.81 earnings per share for the quarter, topping analysts' consensus estimates of $1.46 by $0.35. The business had revenue of $98.92 billion for the quarter, compared to analysts' expectations of $94.87 billion. CVS Health had a net margin of 1.17% and a return on equity of 10.51%. The company's revenue for the quarter was up 8.4% compared to the same quarter last year. During the same quarter last year, the company earned $1.83 EPS. On average, analysts expect CVS Health to post $6 EPS for the current fiscal year and $7 EPS for the next fiscal year.

CVS Health Trading Up 0.7%

CVS Health stock opened at $83.06 on Wednesday. The firm has a 50-day moving average price of $74.70 and a two-hundred day moving average price of $68.36. CVS Health has a 52-week low of $43.56 and a 52-week high of $83.52. The firm has a market capitalization of $105.34 billion, a price-to-earnings ratio of 23.20, a PEG ratio of 0.91 and a beta of 0.60. The company has a quick ratio of 0.62, a current ratio of 0.80 and a debt-to-equity ratio of 0.74.

CVS Health Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Monday, November 3rd. Investors of record on Thursday, October 23rd will be given a $0.665 dividend. This represents a $2.66 annualized dividend and a yield of 3.2%. The ex-dividend date is Thursday, October 23rd. CVS Health's dividend payout ratio (DPR) is currently 74.30%.

Insider Transactions at CVS Health

In other CVS Health news, Director Anne A. Finucane sold 7,500 shares of the company's stock in a transaction on Wednesday, August 20th. The stock was sold at an average price of $71.02, for a total value of $532,650.00. Following the transaction, the director owned 22,156 shares of the company's stock, valued at approximately $1,573,519.12. This represents a 25.29% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 1.22% of the company's stock.

Institutional Investors Weigh In On CVS Health

Several hedge funds have recently modified their holdings of the stock. Ameriprise Financial Inc. increased its stake in CVS Health by 5.2% in the 2nd quarter. Ameriprise Financial Inc. now owns 7,855,845 shares of the pharmacy operator's stock worth $541,903,000 after purchasing an additional 385,806 shares in the last quarter. Raymond James Financial Inc. increased its position in shares of CVS Health by 4.4% in the second quarter. Raymond James Financial Inc. now owns 3,191,584 shares of the pharmacy operator's stock worth $220,155,000 after acquiring an additional 133,875 shares in the last quarter. Adage Capital Partners GP L.L.C. raised its holdings in shares of CVS Health by 43.2% during the second quarter. Adage Capital Partners GP L.L.C. now owns 1,609,599 shares of the pharmacy operator's stock valued at $111,030,000 after acquiring an additional 485,825 shares during the period. Alliancebernstein L.P. boosted its stake in CVS Health by 8.0% in the 2nd quarter. Alliancebernstein L.P. now owns 1,609,404 shares of the pharmacy operator's stock worth $111,017,000 after purchasing an additional 119,439 shares during the period. Finally, Canada Pension Plan Investment Board grew its position in CVS Health by 67.9% during the 2nd quarter. Canada Pension Plan Investment Board now owns 1,541,842 shares of the pharmacy operator's stock worth $106,356,000 after purchasing an additional 623,715 shares in the last quarter. 80.66% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of research analysts have issued reports on CVS shares. The Goldman Sachs Group started coverage on CVS Health in a research report on Tuesday, October 14th. They set a "buy" rating and a $91.00 price target for the company. Truist Financial set a $92.00 target price on shares of CVS Health in a research report on Tuesday, October 14th. Weiss Ratings restated a "hold (c)" rating on shares of CVS Health in a research report on Tuesday, October 14th. Morgan Stanley increased their price objective on shares of CVS Health from $82.00 to $89.00 and gave the company an "overweight" rating in a report on Tuesday, October 14th. Finally, Barclays boosted their target price on CVS Health from $80.00 to $87.00 and gave the stock an "overweight" rating in a report on Thursday, September 4th. Two research analysts have rated the stock with a Strong Buy rating, twenty have issued a Buy rating and four have issued a Hold rating to the company's stock. According to MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average target price of $82.57.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.